ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to ...
ARS as a commercial company. It was a year focused on building infrastructure, educating the market and learning as we ...
Good morning, and welcome to ARS Pharmaceuticals First Quarter 2026 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I will now turn the ...
U.S. net product revenue of $17.5 million CVS Caremark proposal in final stages of approval process; definitive update ...
Indolent systemic mastocytosis (ISM) can cause life-disrupting symptoms. However, most people with the condition have a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results